10 best-performing funds of 2019, so far

11 10 9 8 7 6 5 4 321

ARK Genomic Revolution

Next »« Back

2019 return: 43.51%
12-month trailing return: 21.11%
Ticker symbol: ARKG
Assets: $448.6 million
Expense ratio: 0.75%

Here are the equity mutual funds and ETFs that raced past the competition in the first half.

Here are the equity mutual funds and ETFs that raced past the competition in the first half.

Here are the equity mutual funds and ETFs that raced past the competition in the first half.